Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
about
Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infectionComplement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infectionA novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase metabolism profile.Advances in developing HIV-1 viral load assays for resource-limited settingsPredominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.Development of a generic microfluidic device for simultaneous detection of antibodies and nucleic acids in oral fluids.Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation.Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS.A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay.Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya.Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and OPrevalence of human immunodeficiency virus type 1 (HIV-1) non-B subtypes in foreigners living in Madrid, Spain, and comparison of the performances of the AMPLICOR HIV-1 MONITOR version 1.0 and the new automated version 1.5.One-tube real-time isothermal amplification assay to identify and distinguish human immunodeficiency virus type 1 subtypes A, B, and C and circulating recombinant forms AE and AGNuclear RNA export and packaging functions of HIV-1 Rev revisitedAntenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.An integrated, self-contained microfluidic cassette for isolation, amplification, and detection of nucleic acidsCharacterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis.Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaqueComparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors.Comparison of the sensitivities of the version 1.5 and version 1.0 ultrasensitive Roche AMPLICOR HIV-1 MONITOR kits at low concentrations of human immunodeficiency virus RNAThe perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columnsDetection of HIV-1 neutralizing antibodies in a human CD4⁺/CXCR4⁺/CCR5⁺ T-lymphoblastoid cell assay system.Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1.Determination of HIV Status in African Adults With Discordant HIV Rapid Tests.Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIVRates of and reasons for failure of commercial human immunodeficiency virus type 1 viral load assays in BrazilVirus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeysDiscovery of a small-molecule antiviral targeting the HIV-1 matrix protein.Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaquesUnexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis.PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.RT-PCR detection of HIV in Republic of Macedonia.Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms.PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells.Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests.
P2860
Q28748901-72601C12-7E30-4F0F-BD36-BEFB87E2CCCFQ28766705-42DBBA13-6064-4408-9C76-2A49188D0E57Q30429621-69B0BD66-B8DE-4569-B8AC-8B1DBD9DCD59Q30473238-D1F27F36-B18A-41D1-897F-3D63E5366CF3Q30480959-7943FD60-61CE-40E4-851F-21695FF9961EQ30537014-6760B99E-0781-4AB6-975C-5A2E1EED9F87Q33282047-0A3910DA-EA33-43E6-9FA8-ADDFFE2AF216Q33625721-7D25509C-F436-48DD-91A7-58C25370C07FQ33889449-3EF3F6CD-2F57-4142-8EB1-55F0A097E2BCQ33963347-049835A8-DF29-42F6-8874-259F231AFCE1Q33968241-F2DFD6BC-3F4F-401C-9597-CCC8D727820EQ33971897-B768E89F-1DC3-4E8A-AC47-FA91D557D0B0Q33972274-064DD823-D0E5-4422-B81C-8E7DA444CF2FQ33972312-0C1400C1-B556-4952-A70A-844FA3DA2CF4Q33990559-4B92FB74-E273-48AD-BA93-37DA6C1A25ECQ34057338-E346E2FE-28B7-432D-AD16-8E6942CAD786Q34076494-EC423104-C022-47CB-B1AC-E5BE0ED105ADQ34120302-2FC134F6-013F-41C4-8DAA-67CBEF792AA4Q34325846-26233AA2-7B11-45E8-A503-2C35F04B53DCQ34475019-D97E4D49-96A2-4893-BEA9-18C6C05B01D2Q34487510-E4CD7597-6E70-4914-80CE-E58C0A50DE85Q34507124-A96C6DC3-2203-4D66-8D5B-018F57929938Q34782631-D1DA451D-CD81-4DB5-88BE-F48A79480E0AQ34985551-CCBD79AC-85A5-446F-906C-EE7096992ED9Q35060140-FED14EE5-D611-4760-89AB-AB27B45A2BA2Q35682519-B80B37DC-3203-41B1-A786-FAD7DD4AAF9CQ35789047-674785C1-8256-444F-AB17-CBEC5AE2A7A1Q35837184-0E391E53-30CA-4FD6-A1FD-076DACAE16FFQ35913979-0D3D205F-751F-4EC9-92B1-0CCFC9052B1AQ35947635-3A23C6D7-B5B8-40CC-AB06-DF62227C621BQ36569418-06F1FC97-E935-420B-A366-C4DF03F414A4Q36570464-AC362B68-2B93-42E1-825D-EB357C27DB01Q36576084-48E3CCDD-D36F-4565-916B-73AF56CF93D1Q37089562-F8D382E7-361E-4357-8728-853586B9A70DQ37568313-808E4273-50C1-47F1-B119-5C85C57162B4Q37638811-46625C25-A59F-4EFE-8BE8-6FDCCB264014Q37855816-ED351637-B95C-43FA-BC0E-1A5F956AC20AQ39451075-C0BE35A0-92EF-4B79-95FA-4E0D00FCA67CQ39455247-483DAE61-E9F1-4F95-8621-121426A861B0Q39456289-B43878CB-12FC-4684-9DF6-5F4FEE69BA58
P2860
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Development of calibrated vira ...... h isolates of diverse subtypes
@en
Development of calibrated vira ...... isolates of diverse subtypes.
@nl
type
label
Development of calibrated vira ...... h isolates of diverse subtypes
@en
Development of calibrated vira ...... isolates of diverse subtypes.
@nl
prefLabel
Development of calibrated vira ...... h isolates of diverse subtypes
@en
Development of calibrated vira ...... isolates of diverse subtypes.
@nl
P2093
P2860
P1476
Development of calibrated vira ...... h isolates of diverse subtypes
@en
P2093
C Christopherson
F E McCutchan
J P Spadoro
J R Mascola
L L Jagodzinski
P2860
P304
P407
P577
1999-08-01T00:00:00Z